Therapeutic targeting of lysosome-triggered inflammatory channels in nasal and upper-airway allergic conditions - Takeaways - MDSpire

Therapeutic targeting of lysosome-triggered inflammatory channels in nasal and upper-airway allergic conditions

  • By

  • Haoran Yu

  • Yujin Zheng

  • Daquan Wu

  • Lei Zhou

  • Kanglun Jiang

  • Kaisai Tian

  • Na Shen

  • May 26, 2026

Share

  • 1

    Nasal and upper airway allergic disorders significantly impact global health, causing symptoms that impair quality of life and increase healthcare costs.

  • 2

    Lysosomes play a crucial role in airway inflammation by activating immunological signaling and releasing pro-inflammatory cytokines through calcium signaling.

  • 3

    The NLRP3 inflammasome is a key player in allergic inflammation, promoting the release of IL-1β and macrophage pyroptosis in the nasal mucosa.

  • 4

    Targeting lysosomal ion channels, such as TPCs and TRPML, offers promising therapeutic strategies to reduce inflammation and systemic side effects.

  • 5

    Re-evaluating lysosomes as active signaling hubs opens new avenues for precision-based therapies in allergic airway inflammation.

Original Source(s)

Therapeutic targeting of lysosome-triggered inflammatory channels in nasal and upper-airway allergic conditions

  • by Haoran Yu, Yujin Zheng, Daquan Wu, Lei Zhou, Kanglun Jiang, Kaisai Tian, Na Shen

  • May 26, 2026

Related Content

Can Lower Music Levels Preserve Workout Intensity?

Despite preserved exertion perceptions, researchers report limited hearing protection use in group fitness classes.

The Bill Nobody's Discussing in the Exam Room

Head and neck cancer costs are crushing patients — yet cost discussions remain uncommon in clinical care.

Reduced-Dose Radiation Shows Durable Control

Single-arm cohort findings contrast with interim results from NRG-HN005, underscoring ongoing uncertainty around treatment deintensification.